The latest News

Keep in Touch with Cellestia.


The latest News

Keep in Touch with Cellestia.

February 2019

IND accepted by the FDA

On Feb. 4th, Cellestia received the green light from the FDA for its Investigational New Drug Application (IND). The FDA completed its review, and concluded that Cellestia can proceed with its clinical investigation of CB-103 in tumors driven by an oncogenic NOTCH signaling pathway.

December 2018

Cellestia Biotech AG secures CHF 20 million in Series A funding

Cellestia announced today the close of a CHF 20 million Series A financing round. The financing will accelerate Cellestia’s ongoing clinical program, and advance its innovative R&D pipeline.
To read Cellestia’s press release click here.

September 2018

Cellestia Winner of Venture Leaders China 2018

Cellestia selected as one of the 10 high growth Swiss start-ups composing the new Swiss National Startup Team. The team will fly to China for an exclusive 10-day roadshow for business and investor meetings in September organised by Venture Leaders / swissnex China, including the World Economic Forum Annual Meeting of New Champions in Tianjin